Connect with us

CBD News

Cannabidiol (CBD) Is Best-Selling Herbal Supplement In Natural Sector Of US



  • CBD pushed turmeric out of the top place as the best-selling herbal supplement.
  • The report also reported on changes in the mainstream channel.

Cannabidiol, or CBD, is presently legal at the federal level, assuming that it is derived from hemp. While the Food and Drug Administration (FDA) has yet to implement regulations regarding the use of CBD as an ingredient in supplements, it can independently be used as a supplement, which is boding well. In fact, according to the 2018 HerbalGram Herb Market, the substance is presently considered to be the best-selling herbal supplement of the natural channel.

CBD boasts 32% growth year-on-year, as well as $52 million in sales, and natural retailers are presently the stores benefiting from these sales. Even with regulatory uncertainty, the Herb Market Report shows that alcohol-free tinctures account for about 60% of the CBD products that the US natural channel sells.

The report adds, “The vast majority of the CBD products were marketed for ‘nonspecific health focuses,’ with mood support and sleep as the next most-popular uses.”

Presently, at least in the mass channel (Mainstream Multi-Outlet Channel), the products don’t even register in the 40 top-sellers. However, this lack of position could show that a more risk-averse approach is being taken by this group of retailers. CBD’s surge in the natural sector pushed aside the former top herbal supplement, which was turmeric. Turmeric had maintained the first position since 2013, but it now has been pushed down to the number two place with sales of $51.2 million.

In the mainstream channel, the big performers were primarily attached to immune health and weight management, according to the report. Goji berry showed the highest year-on-year growth at 637%, posting sales of $10.4 million. Other herbs linked with health and weight management included elderberry (138% year-over-year growth) and barberry (47% year-over-year growth). Ashwagandha showed 166% year-over-year growth. At the top of the mainstream channel for herbal supplements were Horehound ($147 million in sales) and Echinacea ($110 million).

The natural channel showed massive growth rates for elderberry supplements as well, revealing 94% growth and $25 million in sales, ranking at number 3. “Mushrooms (other)” was the only other herbal supplement to reveal more than 40% year-over-year growth in the natural channel, which included lion’s mane, turkey tail, and Reishi mushrooms.

Tyler Smith, the managing editor of HerbalGram and the lead author of the report, commented on the data, saying that the 2018 herbal supplement “scene” was taken over by a combination of CBD and mushroom products, while “sales growth remained strong” for other herbs and adaptogens. He noted that he was surprised by the sales of goji berry, which had declined in recent years, among other supplements.

The total sales for mainstream herbal supplements increased to $1.6 billion, while natural channels reported $2.8 billion in increase.

Arina has a Master’s degree in Business and lives in Sydney, Australia and is one of our top contributors as a postgraduate qualified writer. While being a Member Of The Appraisal Institute, she focuses her writing efforts on health, home, business, technology and now cannabis/cbd here.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.